Cite
Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations
MLA
Andersson, Anne Marie C., et al. “Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus Encoded Virus-like Particle Immunizations.” Andersson , A M C , Ragonnaud , E , Seaton , K E , Sawant , S , Folgori , A , Colloca , S , Labranche , C , Montefiori , D C , Tomaras , G D & Holst , P J 2016 , ’ Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus Encoded Virus-like Particle Immunizations ’ , Vaccine , Vol. 34 , No. 44 , Pp. 5344-5351 , 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322687210&authtype=sso&custid=ns315887.
APA
Andersson, A. M. C., Ragonnaud, E., Seaton, K. E., Sawant, S., Folgori, A., Colloca, S., Labranche, C., Montefiori, D. C., Tomaras, G. D., & Holst, P. J. (2016). Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations. Andersson , A M C , Ragonnaud , E , Seaton , K E , Sawant , S , Folgori , A , Colloca , S , Labranche , C , Montefiori , D C , Tomaras , G D & Holst , P J 2016 , ’ Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus Encoded Virus-like Particle Immunizations ’ , Vaccine , Vol. 34 , No. 44 , Pp. 5344-5351 .
Chicago
Andersson, Anne Marie C, Emeline Ragonnaud, Kelly E. Seaton, Sheetal Sawant, Antonella Folgori, Stefano Colloca, Celia Labranche, David C. Montefiori, Georgia D. Tomaras, and Peter J. Holst. 2016. “Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus Encoded Virus-like Particle Immunizations.” Andersson , A M C , Ragonnaud , E , Seaton , K E , Sawant , S , Folgori , A , Colloca , S , Labranche , C , Montefiori , D C , Tomaras , G D & Holst , P J 2016 , ’ Effect of HIV-1 Envelope Cytoplasmic Tail on Adenovirus Primed Virus Encoded Virus-like Particle Immunizations ’ , Vaccine , Vol. 34 , No. 44 , Pp. 5344-5351 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1322687210&authtype=sso&custid=ns315887.